Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis-Reference-Cited by-同舟云学术

Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis

Published:2022-11 Issue: Volume:25 Page:101490
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Zeng Lifeng,Luo Xiaojiang,Zhang Zhiyong,Wang Zhengyong,Qian Jinrong^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global cancer statistics;Torre;CA Cancer J. Clin.,2012

2. Colorectal cancer molecular biology moves into clinical practice;Pritchard;Gut,2011

3. Mortality trends and risk of dying from colorectal cancer in the seven socioeconomic regions of Mexico, 2000–2012;Sanchez-Barriga;Rev. Gastroenterol. Mex.,2017

4. More is less - combining targeted therapies in metastatic colorectal cancer;Punt;Nat. Rev. Clin. Oncol.,2009

5. Immunotherapy for colorectal cancer: a challenge to clinical trial design;Midgley;Lancet Oncol.,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNA-3163 limits ovarian cancer stem-like cells via targeting SOX-2 transcription factor;Non-coding RNA Research;2024-12

2. miRNA and leptin signaling in metabolic diseases and at extreme environments;Pharmacology Research & Perspectives;2024-07-17

3. The functions and mechanisms of long non-coding RNA in colorectal cancer;Frontiers in Oncology;2024-07-04

4. MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer;Cancers;2024-01-31

5. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies;Environmental Research;2023-09